Latest news
CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, September 28, 2026 Lead Plaintiff Deadline - MorningstarMorningstar · Mon, 10 Aug 2026 13:04:31 GMTBronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-DemocratCarroll County Mirror-Democrat · Sun, 09 Aug 2026 16:00:00 GMTKaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (N - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 23:10:09 GMTROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 17:42:46 GMT2026-08-07 | Bronstein, Gewirtz & Grossman, LLC Encourages Capricor Therapeutics, Inc. (CAPR) Stockholders to Inquire about Securities Investigation | NDAQ:CAPR | Press Release - StockhouseStockhouse · Fri, 07 Aug 2026 17:00:00 GMTKaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026 - Barchart.comBarchart.com · Fri, 07 Aug 2026 15:30:00 GMTCAPR: Block & Leviton Encourages Capricor Therapeutics Investors to Seek Appointment as Lead Plaintiff - ACCESS NewswireACCESS Newswire · Thu, 06 Aug 2026 20:44:57 GMTCAPRICOR INVESTOR ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 20:29:21 GMT